Capecitabine-based approach shows promise in a population with few options
Targeting pyrimidine synthesis inhibits GSC self-renewal and tumorigenesis
New center dedicated to studying their role
Established lymphoma/leukemia therapy also targets glioma stem cells
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Newly discovered signaling axis opens therapeutic window